Over the last 12 months, Usana Health Sciences insiders reported no purchases and 16 sales totaling $991K across SEC Form 4 filings.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Neidig BrentCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 5,002 | $19.45 | $97K | -100% | — |
| Jun 15, 2026 | Neidig BrentCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 2,511 | $20.1 | $50K | -33.4% | 2 tranches |
| Jun 8, 2026 | Jones Paul A.CHIEF PEOPLE OFFICER · O | ▼ Sale | 5,561 | $18.5 | $103K | -100% | — |
| Jun 1, 2026 | Fleming John TurmanD | ▼ Sale | 2,450 | $17.93 | $44K | -36.7% | — |
| May 28, 2026 | Jones Paul A.CHIEF PEOPLE OFFICER · O | ▼ Sale | 6,813 | $18.95 | $129K | -55.1% | — |
| May 27, 2026 | IIEKKING G DOUGCHIEF FINANCIAL OFFICER · O | ▼ Sale | 5,360 | $18.75 | $101K | -100% | — |
| May 22, 2026 | FULLER GILBERT AD | ▼ Sale | 1,057 | $18.66 | $20K | -100% | — |
| May 7, 2026 | Foukas JoshuaCHIEF LEGAL OFFICER · O | ▼ Sale | 3,791 | $19.82 | $75K | -100% | — |
| Mar 20, 2026 | FULLER GILBERT AD | ▼ Sale | 1,058 | $17 | $18K | -100% | — |
| Mar 3, 2026 | Benedict PeterCHIEF INFORMATION OFFICER · O | ▼ Sale | 4,553 | $19.38 | $88K | -100% | — |
| Feb 20, 2026 | Foukas JoshuaCHIEF LEGAL OFFICER · O | ▼ Sale | 4,461 | $21.34 | $95K | -100% | — |
| Dec 10, 2025 | Benedict PeterCHIEF INFORMATION OFFICER · O | ▼ Sale | 2,673 | $20.95 | $56K | -100% | — |
| Dec 10, 2025 | Mulham David MulhamCHIEF SALES OFFICER · O | ▼ Sale | 873 | $21 | $18K | -9.4% | — |
| Nov 10, 2025 | Winssinger Frederic JD | ▼ Sale | 2,000 | $19.21 | $38K | -25% | — |
| Nov 3, 2025 | FULLER GILBERT AD | ▼ Sale | 1,057 | $21.48 | $23K | -100% | — |
| Oct 31, 2025 | Fleming John TurmanD | ▼ Sale | 1,750 | $19.79 | $35K | -27.7% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Usana Health Sciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $USNA feed.